NCT04428905
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer No drug interventions supportive_care Not Available active_not_recruiting NCT04593277
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study No drug interventions supportive_care Not Available active_not_recruiting NCT04017650
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer treatment 1 / 2 active_not_recruiting NCT04535401
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines treatment 1 active_not_recruiting NCT04704661
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial treatment 1 recruiting NCT05930496
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT04511039
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer treatment 1 recruiting NCT06626256
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma treatment 1 not_yet_recruiting NCT05518032
Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC) treatment 2 withdrawn NCT05672316
Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients with Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy treatment 1 / 2 active_not_recruiting NCT05967533
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors No drug interventions treatment 1 recruiting NCT03630354
EXERCISING TOGETHER for Couples Coping With Cancer No drug interventions supportive_care Not Available completed NCT03563651
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal Cancers No drug interventions Not Available Not Available completed NCT04117945
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer treatment 2 active_not_recruiting NCT04616183
LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer treatment 1 / 2 active_not_recruiting NCT03520283
Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer Survivors No drug interventions supportive_care Not Available completed NCT03867916
Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients No drug interventions health_services_research Not Available completed NCT04832763
Medical and Psychosocial Issues in Adolescents and Young Adults With Colorectal Cancer No drug interventions other Not Available terminated NCT04119830
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal Cancer treatment 2 withdrawn NCT04111172
A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma No drug interventions treatment 2 suspended NCT04739072
Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study No drug interventions Not Available Not Available recruiting NCT03796884
Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer treatment 2 active_not_recruiting NCT04449679
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS Study No drug interventions supportive_care Not Available completed NCT04597151
Diet Education Program for Stage I-IV Colorectal Cancer Survivors No drug interventions supportive_care Not Available completed NCT02983578
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer treatment 2 active_not_recruiting NCT03781778
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer Survivors No drug interventions prevention 2 terminated NCT04137107
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer supportive_care 2 / 3 active_not_recruiting NCT03992456
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer treatment 2 active_not_recruiting NCT05733000
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors treatment 2 recruiting NCT04501913
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported Outcomes No drug interventions Not Available Not Available active_not_recruiting NCT04096417
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations treatment 2 active_not_recruiting NCT04109924
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO Study treatment 2 active_not_recruiting NCT06016725
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF Trial No drug interventions supportive_care Not Available recruiting NCT06575725
Botensilimab, Balstilimab and Regorafenib or Botensilimab and Balstilimab for the Treatment of Advanced or Metastatic Microsatellite Stable Colorectal Cancer treatment 2 not_yet_recruiting NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study No drug interventions Not Available Not Available active_not_recruiting NCT03844620
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer treatment 2 active_not_recruiting NCT02595931
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 active_not_recruiting NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer No drug interventions screening 0 completed NCT05691491
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness treatment 1 / 2 recruiting